EV Biologics, Inc. (YECO)

0.6021 -0.0200 (-3.21%) 收市：09:59AM EDT

EV Biologics, Inc.

1621 Central Avenue
Cheyenne, WY 82001
United States
206-734-4738
https://www.evbiologics.com

版塊: Healthcare
行業: Biotechnology
全職員工: 284

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Daniel S. McKinney	Founder, Chairman & CEO	無	無	1962
Mr. Monte Fisher	Chief Financial Officer	無	無	無
Mr. William Bossung	Corporate Finance Director & Corporate Secretary	無	無	無

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

公司管治

截至 無 止，EV Biologics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。